What is Kinomatic?
Kinomatic operates at the intersection of medical technology and digital health, specializing in custom surgical planning for knee and hip replacements. The company utilizes innovative VR technology to generate ultra-realistic 3D models, allowing surgeons to simulate and optimize procedures with unprecedented precision. By focusing on natural biomechanical alignment, Kinomatic addresses a critical need for personalized surgical solutions that enhance patient recovery times and long-term satisfaction. Their platform serves as a sophisticated bridge between diagnostic imaging and surgical execution, providing clinics with the tools necessary to deliver bespoke care in an increasingly standardized medical landscape.
How much funding has Kinomatic raised?
Kinomatic has raised a total of $4M across 1 funding round:
Stock/Share Issuance
$4M
Stock/Share Issuance (2026): $4M, investors not publicly disclosed
Key Investors in Kinomatic
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Kinomatic?
With this major strategic investment, Kinomatic is poised to accelerate its enterprise-level expansion and deepen its integration within surgical clinics globally. The company is expected to prioritize the scaling of its AI-enhanced software capabilities, potentially expanding its biomechanical modeling suite to cover a broader range of orthopedic interventions. As the firm transitions into this next phase of growth, the focus will likely shift toward establishing strategic partnerships with major hospital networks and refining its service delivery model to ensure seamless adoption of its VR-based planning tools. This capital infusion provides the necessary runway to solidify Kinomatic's market leadership and drive the adoption of personalized surgical workflows.
See full Kinomatic company page
